198 related articles for article (PubMed ID: 33903881)
1. Progress on the role of reactive oxygen species-mediated tumor microenvironment in pancreatic cancer.
Tao X; Go VLWB; Xiao GG
Sheng Li Xue Bao; 2021 Apr; 73(2):197-207. PubMed ID: 33903881
[TBL] [Abstract][Full Text] [Related]
2. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
3. Tumor Microenvironment and Nitric Oxide: Concepts and Mechanisms.
Vedenko A; Panara K; Goldstein G; Ramasamy R; Arora H
Adv Exp Med Biol; 2020; 1277():143-158. PubMed ID: 33119871
[TBL] [Abstract][Full Text] [Related]
4. Cancer stem cell (CSC) resistance drivers.
Najafi M; Mortezaee K; Majidpoor J
Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
[TBL] [Abstract][Full Text] [Related]
5. Tumor and its microenvironment: a synergistic interplay.
Catalano V; Turdo A; Di Franco S; Dieli F; Todaro M; Stassi G
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):522-32. PubMed ID: 24012661
[TBL] [Abstract][Full Text] [Related]
6. The dynamic interactions between the stroma, pancreatic stellate cells and pancreatic tumor development: Novel therapeutic targets.
Farran B; Nagaraju GP
Cytokine Growth Factor Rev; 2019 Aug; 48():11-23. PubMed ID: 31331827
[TBL] [Abstract][Full Text] [Related]
7. Regulation of tumor microenvironment for pancreatic cancer therapy.
Huang X; Ding L; Liu X; Tong R; Ding J; Qian Z; Cai L; Zhang P; Li D
Biomaterials; 2021 Mar; 270():120680. PubMed ID: 33588140
[TBL] [Abstract][Full Text] [Related]
8. The Microenvironment of Lung Cancer and Therapeutic Implications.
Mittal V; El Rayes T; Narula N; McGraw TE; Altorki NK; Barcellos-Hoff MH
Adv Exp Med Biol; 2016; 890():75-110. PubMed ID: 26703800
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic cancer stem cells: new insight into a stubborn disease.
Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
[TBL] [Abstract][Full Text] [Related]
10. Tumor microenvironment in chemoresistance, metastasis and immunotherapy of pancreatic cancer.
Wang S; Li Y; Xing C; Ding C; Zhang H; Chen L; You L; Dai M; Zhao Y
Am J Cancer Res; 2020; 10(7):1937-1953. PubMed ID: 32774994
[TBL] [Abstract][Full Text] [Related]
11. Reactive Oxygen Species-Mediated Tumor Microenvironment Transformation: The Mechanism of Radioresistant Gastric Cancer.
Gu H; Huang T; Shen Y; Liu Y; Zhou F; Jin Y; Sattar H; Wei Y
Oxid Med Cell Longev; 2018; 2018():5801209. PubMed ID: 29770167
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer stemness: dynamic status in malignant progression.
Zhao Y; Qin C; Zhao B; Wang Y; Li Z; Li T; Yang X; Wang W
J Exp Clin Cancer Res; 2023 May; 42(1):122. PubMed ID: 37173787
[TBL] [Abstract][Full Text] [Related]
13. Elevated level of mitochondrial reactive oxygen species via fatty acid β-oxidation in cancer stem cells promotes cancer metastasis by inducing epithelial-mesenchymal transition.
Wang C; Shao L; Pan C; Ye J; Ding Z; Wu J; Du Q; Ren Y; Zhu C
Stem Cell Res Ther; 2019 Jun; 10(1):175. PubMed ID: 31196164
[TBL] [Abstract][Full Text] [Related]
14. Cancer stem cells (CSCs) in cancer progression and therapy.
Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
[TBL] [Abstract][Full Text] [Related]
15. Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.
Lee SY; Jeong EK; Ju MK; Jeon HM; Kim MY; Kim CH; Park HG; Han SI; Kang HS
Mol Cancer; 2017 Jan; 16(1):10. PubMed ID: 28137309
[TBL] [Abstract][Full Text] [Related]
16. CCL21/CCR7 Axis Contributed to CD133+ Pancreatic Cancer Stem-Like Cell Metastasis via EMT and Erk/NF-κB Pathway.
Zhang L; Wang D; Li Y; Liu Y; Xie X; Wu Y; Zhou Y; Ren J; Zhang J; Zhu H; Su Z
PLoS One; 2016; 11(8):e0158529. PubMed ID: 27505247
[TBL] [Abstract][Full Text] [Related]
17. Encapsulated human mesenchymal stem cells (eMSCs) as a novel anti-cancer agent targeting breast cancer stem cells: Development of 3D primed therapeutic MSCs.
Mandal S; Arfuso F; Sethi G; Dharmarajan A; Warrier S
Int J Biochem Cell Biol; 2019 May; 110():59-69. PubMed ID: 30735730
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment and noncoding RNAs as co-drivers of epithelial-mesenchymal transition and cancer metastasis.
Drak Alsibai K; Meseure D
Dev Dyn; 2018 Mar; 247(3):405-431. PubMed ID: 28691356
[TBL] [Abstract][Full Text] [Related]
19. Whom to blame for metastasis, the epithelial-mesenchymal transition or the tumor microenvironment?
Pietilä M; Ivaska J; Mani SA
Cancer Lett; 2016 Sep; 380(1):359-68. PubMed ID: 26791236
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial-mesenchymal transition and cancer stem cell-like properties by modulating forkhead box protein M1.
Cao J; Li J; Sun L; Qin T; Xiao Y; Chen K; Qian W; Duan W; Lei J; Ma J; Ma Q; Han L
Mol Oncol; 2019 Feb; 13(2):228-245. PubMed ID: 30367545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]